Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden flag Sweden · Delayed Price · Currency is SEK
17.14
-0.32 (-1.83%)
At close: Mar 6, 2026

Cinclus Pharma Holding AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Revenue
57.474.585.9610.57-
Upgrade
Revenue Growth (YoY)
1154.80%-23.14%-43.63%--
Upgrade
Gross Profit
57.474.585.9610.57-
Upgrade
Selling, General & Admin
57.2536.8539.5664.1214.45
Upgrade
Research & Development
198.4136.66166.68157.1869.82
Upgrade
Operating Expenses
255.65173.51206.24221.384.27
Upgrade
Operating Income
-198.18-168.93-200.28-210.73-84.27
Upgrade
Interest Expense
--8.73-7.45-0.08-0.01
Upgrade
Interest & Investment Income
15.8511.213.031.18-
Upgrade
Currency Exchange Gain (Loss)
-1.38-2.08-10.49-21.398.01
Upgrade
Other Non Operating Income (Expenses)
01.240.5800
Upgrade
Pretax Income
-183.71-167.28-214.61-231.01-76.27
Upgrade
Income Tax Expense
0.260.750.5118.06-
Upgrade
Net Income
-183.97-168.03-215.12-249.07-76.27
Upgrade
Net Income to Common
-183.97-168.03-215.12-249.07-76.27
Upgrade
Shares Outstanding (Basic)
4737262321
Upgrade
Shares Outstanding (Diluted)
4737262321
Upgrade
Shares Change (YoY)
25.69%41.26%13.81%9.26%8415.70%
Upgrade
EPS (Basic)
-3.95-4.54-8.20-10.81-3.62
Upgrade
EPS (Diluted)
-3.95-4.54-8.20-10.81-3.62
Upgrade
Free Cash Flow
-74.65-178.37-209.19-192.08-75.48
Upgrade
Free Cash Flow Per Share
-1.60-4.81-7.98-8.34-3.58
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%-
Upgrade
Operating Margin
-344.84%-3688.45%-3360.98%-1993.45%-
Upgrade
Profit Margin
-320.12%-3668.80%-3609.97%-2356.20%-
Upgrade
Free Cash Flow Margin
-129.89%-3894.48%-3510.42%-1817.01%-
Upgrade
EBITDA
-195.8-168.9-200.25-210.69-84.26
Upgrade
D&A For EBITDA
2.380.030.030.040.01
Upgrade
EBIT
-198.18-168.93-200.28-210.73-84.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.